Elmiron and Ranexa drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Elmiron (pentosan polysulfate sodium) and Ranexa (ranolazine). Common drug interactions include renal disorder among females and death among males.

The phase IV clinical study analyzes what interactions people have when they take Elmiron and Ranexa. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Elmiron?

Elmiron has active ingredients of pentosan polysulfate sodium. It is often used in interstitial cystitis (ic). eHealthMe is studying from 10,215 Elmiron users. Check the latest studies of Elmiron.

What is Ranexa?

Ranexa has active ingredients of ranolazine. It is often used in angina. eHealthMe is studying from 11,758 Ranexa users. Check the latest studies of Ranexa.



On Jul, 15, 2026

18 people who take Elmiron and Ranexa together, and have interactions are studied.

Elmiron and Ranexa drug interactions.

What are the common drug interactions of Elmiron and Ranexa, by gender? *:

female:

  1. Renal disorder (kidney disease)
  2. Road traffic accident
  3. Maculopathy (a condition or disease of the macula, the small spot in the retina where vision is keenest)
  4. Age-related macular degeneration
  5. Vitreous detachment (a condition of the eye in which the vitreous humour separates from the retina)
  6. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  7. Cardiac disorder
  8. Retinal pigmentation (pigmentation of retina)
  9. Visual impairment
  10. Hypertension (high blood pressure)

male:

  1. Death
  2. Plasma cell myeloma (cancer that begins in plasma cells)

What are the common drug interactions of Elmiron and Ranexa, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Maculopathy (a condition or disease of the macula, the small spot in the retina where vision is keenest)
  2. Age-related macular degeneration

60+:

  1. Age-related macular degeneration
  2. Vitreous detachment (a condition of the eye in which the vitreous humour separates from the retina)
  3. Death
  4. Plasma cell myeloma (cancer that begins in plasma cells)

What are the existing conditions these people have? *

  1. Cystitis Interstitial (unknown cause characterized by bladder pain): 10 people, 55.56%
  2. Cardiac Disorder: 7 people, 38.89%
  3. High Blood Cholesterol: 7 people, 38.89%
  4. High Blood Pressure: 6 people, 33.33%
  5. Fibromyalgia (a long-term condition which causes pain all over the body): 4 people, 22.22%
  6. Gastric Disorder (disease of stomach): 3 people, 16.67%
  7. Injury: 3 people, 16.67%
  8. Chest Pain: 3 people, 16.67%
  9. Depression: 3 people, 16.67%
  10. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 16.67%

* Approximation only. Some reports may have incomplete information.

Do you take Elmiron and Ranexa?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Elmiron and Ranexa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Elmiron:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ranexa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Elmiron and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ranexa and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on pentosan polysulfate sodium and ranolazine (the active ingredients of Elmiron and Ranexa, respectively), and Elmiron and Ranexa (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: